akebia.com Open in urlscan Pro
141.193.213.21  Public Scan

Form analysis
2 forms found in the DOM

GET https://akebia.com/

<form role="search" method="get" class="et-search-form" action="https://akebia.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:"> <button type="submit" id="searchsubmit_header"></button>
</form>

GET https://akebia.com/

<form role="search" method="get" class="et-search-form" action="https://akebia.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

Text Content

 * Home
 * About
 * Our Medicine
 * Research & Development
 * Partnering
 * Investors
 * Join Us
 * Connect
 * …………………………
 * Understanding Kidney Disease
 * Patients & Families
 * Medical Professionals


Menu



COMMITTED

Advancing new hope for
people with kidney disease

RESEARCH & DEVELOPMENT


INNOVATION

Making a difference by
challenging the status quo

OUR MEDICINE


COLLABORATION

We are better together

JOIN US
Video Player
00:03
00:00
00:07
Use Up/Down Arrow keys to increase or decrease volume.


PreviousNext
;


A TRUSTED LEADER IN THE RENAL COMMUNITY DELIVERING UNIQUE PRODUCTS TO PEOPLE
WITH KIDNEY DISEASE.

We are a fully integrated biopharmaceutical company. Our team works to address
complications of kidney disease. We have both a commercially available medicine
and a late stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor
(HIF-PHI), vadadustat.  Vadadustat and other HIF-PHIs are based on Nobel
Prize-winning science.

VAFSEO® (vadadustat)is approved for use in 34 countries. Vadadustat has not been
approved by the U.S. Food & Drug Administration.

LEARN MORE
Our Medicine

Research & Development



BE PART OF A PASSIONATE TEAM WORKING TO PROTECT THE KIDNEYS AND TO INNOVATE FOR
BETTER LIVES

JOIN US


NEARLY 37 MILLION AMERICANS

are currently affected by chronic kidney disease.

Chronic kidney disease is a serious and life-altering illness that is
persistent, progressive, and irreversible.

Reference
Centers for Disease Control and Prevention. Chronic Kidney Disease in the United
States, 2019. Available at:
https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html.
Accessed: September 3, 2019.
Understanding Kidney Disease

Patients & Families

Medical Professionals


NEWS

For the latest news from Akebia, visit our Investors page.

VIEW ALL NEWS

BC-0014   (v5.0)   06/23

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us

 * Follow
 * Follow
 * Follow

© 2023 Akebia Therapeutics, Inc. All rights reserved.

Akebia Therapeutics® and its associated logos are trademarks of Akebia and/or
its affiliates. All other trademarks and registered trademarks, trade names and
service marks referred to herein are the property of their respective owners.
Akebia is not associated with or sponsored by the trademark owners.  

Terms of Use    /    Privacy Policy   /   Social Media Guidelines   /   Note
Regarding Forward Looking Statements   /   Website by D&CO

You are leaving akebia.com, a website of Akebia Therapeutics, Inc. Akebia does
not review or control the content of non-Akebia websites, and this hyperlink
does not constitute an endorsement by Akebia of the site’s content. Akebia’s
privacy procedures do not apply to the owners of a non-Akebia website.
CONTINUE
×


PRIVACY PREFERENCE CENTER

When you visit any web site, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Allow All


MANAGE COOKIE PREFERENCES

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site.    All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.


Confirm My Choices

Back Button

Back


PERFORMANCE COOKIES

Vendor Search Search Icon Filter Icon


Clear Fliters

Information storage and access
Apply

All Consent Allowed

Select All Vendors
All Consent Allowed


 * 33ACROSS
   
   HOST DESCRIPTION
   
   VIEW COOKIES
   
   
   REPLACE-WITH-DYANMIC-HOST-ID
    * Name
      cookie name
      Host
      cookie host
      Duration
      cookie duration
      Type
      cookie type
      Category
      cookie category
      Description
      cookie category


 * 33ACROSS
   
   View Privacy Notice
   
   3 Purposes
   
   REPLACE-WITH-DYANMIC-VENDOR-ID
   Arrow
   
   Consent Purposes
   
   Location Based Ads
   
   Consent Allowed
   
   Legitimate Interest Purposes
   
   Personalize
   
   Require Opt-Out
   
   Features
   
   Location Based Ads

Confirm My Choices


Our website uses cookies to improve usability. By using the website, you agree
to the Cookie Policy. By clicking on the “Cookie Settings” link, you can adapt
the use of cookies according to your preferences.

Cookies Settings Accept Cookies